Register
Login:
Share:
Email Facebook Twitter




Shire Share Chat (SHP)



Share Price: 4,289.00Bid: 4,288.00Ask: 4,289.00Change: 0.00 (0.00%)No Movement on Shire
Spread: 1.00Spread as %: 0.02%Open: 4,345.00High: 4,352.00Low: 4,265.00Yesterday’s Close: 4,289.00


Share Discussion for Shire


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


riddock57
Posts: 309
Observation
Opinion:No Opinion
Price:4,187.00
Shire (SHP) Time to Watch It
28 Apr '16
 
faramog
Posts: 108
Off Topic
Opinion:Buy
Price:4,173.00
news
27 Apr '16
Brussels, 27 April 2016 The European Commission has approved under the EU Merger Regulation the acquisition of Baxalta Inc. by Shire plc. Baxalta is a global pharmaceutical company incorporated in the United States. It specialises in rare diseases and advancing innovative therapies in haematology, immunology and oncology. Shire is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company active in neuroscience, gastrointestinal and internal medicine, ophthalmics and rare diseases. The Commission concluded that the proposed acquisition would raise no competition concerns. Although both companies focus on the development of treatments for specific rare diseases, they target different diseases with dissimilar therapeutic indications and only have in common the fact that a small number of patients suffers from these diseases. Their businesses are therefore complementary. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.7951. - See more at: http://crweworld.com/article/news/26067/mergers-commission-clears-acquisition-of-baxalta-by-shire#sthash.SXT0rMQX.dpuf
faramog
Posts: 108
Off Topic
Opinion:Buy
Price:4,173.00
news
27 Apr '16
Brussels, 27 April 2016 The European Commission has approved under the EU Merger Regulation the acquisition of Baxalta Inc. by Shire plc. Baxalta is a global pharmaceutical company incorporated in the United States. It specialises in rare diseases and advancing innovative therapies in haematology, immunology and oncology. Shire is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company active in neuroscience, gastrointestinal and internal medicine, ophthalmics and rare diseases. The Commission concluded that the proposed acquisition would raise no competition concerns. Although both companies focus on the development of treatments for specific rare diseases, they target different diseases with dissimilar therapeutic indications and only have in common the fact that a small number of patients suffers from these diseases. Their businesses are therefore complementary. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.7951. - See more at: http://crweworld.com/article/news/26067/mergers-commission-clears-acquisition-of-baxalta-by-shire#sthash.SXT0rMQX.dpuf
riddock57
Posts: 309
Observation
Opinion:No Opinion
Price:4,173.00
Shire (SHP) Potential Reaction
27 Apr '16
Watch Shire (SHP) closely @ current levels. Potential reaction to European Commission's determination on Baxalta's acquisition by the company

Check this out

http://crweworld.com/article/news/26067/mergers-commission-clears-acquisition-of-baxalta-by-shire
mrcautious
Posts: 226
Off Topic
Opinion:No Opinion
Price:4,065.00
Great Potential
5 Apr '16
I have a position in this in my SIPP and trading account, it is still a gift
Rhambo
Posts: 1,619
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:3,634.00
RE: Momentum on Shire (SHP)
18 Mar '16
Looks like there is value in this at these levels.
riddock57
Posts: 309
Observation
Opinion:No Opinion
Price:3,897.00
Momentum on Shire (SHP)
28 Feb '16
Keep a close eye on Shire (SHP) on investment analysts' perspective

Check this out

http://crweworld.com/article/markets/19890/shire-shpg-and-astrazeneca-azn-momentum-under-cantor-fitzgerald-perspective
riddock57
Posts: 309
Observation
Opinion:No Opinion
Price:3,568.00
Time to Look at Shire (SHP)
11 Feb '16
notgreedy
Posts: 1,016
Off Topic
Opinion:No Opinion
Price:3,717.00
RE: Time to Watch Shire (SHP)
3 Feb '16
Maybe now. I'll be brave and get a bit positive with smallish( parallel) long.
notgreedy
Posts: 1,016
Off Topic
Opinion:No Opinion
Price:3,879.00
RE: Time to Watch Shire (SHP)
28 Jan '16
Not yet. I don't put much value to brokers bs. They are pushing their own positions. On the other hand, today's c r ratings are nothing to shout about. Not that I think shp sp should be any higher any time soon, due to financials trickling down to us pis, but purely cos of necessity and mechanics of volatility, I shall reduce a bit my shorts and start smallish parallel longs for short play. I could be wrong but I still believe sp will come to low £30's in this tax year. Thank you shp bod for your good work.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.